

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.82110139 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 5.07838203 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.98849174 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.98849174 |
| 5 | chaperone-mediated protein transport (GO:0072321) | 4.93473349 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.91153513 |
| 7 | viral transcription (GO:0019083) | 4.85780698 |
| 8 | translational termination (GO:0006415) | 4.80220432 |
| 9 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.77195877 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 4.69764335 |
| 11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.47611726 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 4.42978756 |
| 13 | protein targeting to ER (GO:0045047) | 4.37961623 |
| 14 | establishment of integrated proviral latency (GO:0075713) | 4.30363225 |
| 15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.21517604 |
| 16 | response to peptidoglycan (GO:0032494) | 4.16425379 |
| 17 | translational elongation (GO:0006414) | 4.15883038 |
| 18 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.14988500 |
| 19 | protein localization to endoplasmic reticulum (GO:0070972) | 4.08518110 |
| 20 | regulation of mitochondrial translation (GO:0070129) | 4.08100057 |
| 21 | superoxide anion generation (GO:0042554) | 4.00235594 |
| 22 | translational initiation (GO:0006413) | 4.00138182 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 3.96749295 |
| 24 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.94449200 |
| 25 | translation (GO:0006412) | 3.91453782 |
| 26 | protein complex biogenesis (GO:0070271) | 3.90201630 |
| 27 | respiratory electron transport chain (GO:0022904) | 3.89169613 |
| 28 | histone exchange (GO:0043486) | 3.86016508 |
| 29 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.84300266 |
| 30 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.81877077 |
| 31 | NADH dehydrogenase complex assembly (GO:0010257) | 3.81877077 |
| 32 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.81877077 |
| 33 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.79501911 |
| 34 | electron transport chain (GO:0022900) | 3.79390430 |
| 35 | pseudouridine synthesis (GO:0001522) | 3.74217498 |
| 36 | purine nucleobase biosynthetic process (GO:0009113) | 3.68512976 |
| 37 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.67840880 |
| 38 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.66080279 |
| 39 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.65129857 |
| 40 | protein neddylation (GO:0045116) | 3.64934181 |
| 41 | cellular protein complex disassembly (GO:0043624) | 3.63735693 |
| 42 | viral life cycle (GO:0019058) | 3.63515382 |
| 43 | DNA strand elongation (GO:0022616) | 3.61956017 |
| 44 | protein localization to kinetochore (GO:0034501) | 3.58106731 |
| 45 | DNA replication-independent nucleosome organization (GO:0034724) | 3.52705125 |
| 46 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.52705125 |
| 47 | nucleobase biosynthetic process (GO:0046112) | 3.52316028 |
| 48 | cellular component biogenesis (GO:0044085) | 3.51070632 |
| 49 | spliceosomal snRNP assembly (GO:0000387) | 3.48935252 |
| 50 | rRNA metabolic process (GO:0016072) | 3.48375134 |
| 51 | formation of translation preinitiation complex (GO:0001731) | 3.44672055 |
| 52 | negative regulation of ligase activity (GO:0051352) | 3.41009104 |
| 53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.41009104 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.39213999 |
| 55 | respiratory chain complex IV assembly (GO:0008535) | 3.35076651 |
| 56 | natural killer cell mediated immunity (GO:0002228) | 3.34375516 |
| 57 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.34375516 |
| 58 | establishment of viral latency (GO:0019043) | 3.32666880 |
| 59 | protein targeting to mitochondrion (GO:0006626) | 3.30947738 |
| 60 | maturation of 5.8S rRNA (GO:0000460) | 3.30076423 |
| 61 | negative regulation by host of viral transcription (GO:0043922) | 3.29455652 |
| 62 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.26681395 |
| 63 | telomere maintenance via recombination (GO:0000722) | 3.25819711 |
| 64 | histone mRNA metabolic process (GO:0008334) | 3.25674786 |
| 65 | IMP biosynthetic process (GO:0006188) | 3.24568189 |
| 66 | cytochrome complex assembly (GO:0017004) | 3.23765383 |
| 67 | positive regulation of interferon-alpha production (GO:0032727) | 3.22910821 |
| 68 | DNA damage response, detection of DNA damage (GO:0042769) | 3.20648482 |
| 69 | kinetochore assembly (GO:0051382) | 3.17716286 |
| 70 | DNA ligation (GO:0006266) | 3.17583055 |
| 71 | respiratory burst (GO:0045730) | 3.17242874 |
| 72 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.17112571 |
| 73 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.17112571 |
| 74 | DNA double-strand break processing (GO:0000729) | 3.16598148 |
| 75 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.16160687 |
| 76 | mitotic recombination (GO:0006312) | 3.15762434 |
| 77 | protein complex disassembly (GO:0043241) | 3.14751652 |
| 78 | granulocyte activation (GO:0036230) | 3.14645774 |
| 79 | kinetochore organization (GO:0051383) | 3.11788725 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 3.09413469 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 3.09413469 |
| 82 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.09413469 |
| 83 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.09413469 |
| 84 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.09413469 |
| 85 | modulation by symbiont of host immune response (GO:0052553) | 3.09413469 |
| 86 | macromolecular complex disassembly (GO:0032984) | 3.09305470 |
| 87 | regulation of RIG-I signaling pathway (GO:0039535) | 3.07500818 |
| 88 | regulation of helicase activity (GO:0051095) | 3.07024761 |
| 89 | establishment of protein localization to mitochondrion (GO:0072655) | 3.05073821 |
| 90 | regulation of interferon-alpha production (GO:0032647) | 3.03748286 |
| 91 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03615657 |
| 92 | rRNA methylation (GO:0031167) | 3.03491215 |
| 93 | protein localization to mitochondrion (GO:0070585) | 3.03171932 |
| 94 | B cell mediated immunity (GO:0019724) | 3.03085904 |
| 95 | reactive oxygen species biosynthetic process (GO:1903409) | 3.02780679 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01951068 |
| 97 | metaphase plate congression (GO:0051310) | 3.01456067 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.01202306 |
| 99 | neutrophil activation (GO:0042119) | 2.99417691 |
| 100 | mRNA catabolic process (GO:0006402) | 2.99351444 |
| 101 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97615107 |
| 102 | oxidative phosphorylation (GO:0006119) | 2.96849112 |
| 103 | inner mitochondrial membrane organization (GO:0007007) | 2.95834150 |
| 104 | regulation of chemokine biosynthetic process (GO:0045073) | 2.95421110 |
| 105 | transcription from mitochondrial promoter (GO:0006390) | 2.95359076 |
| 106 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.95086990 |
| 107 | proteasome assembly (GO:0043248) | 2.95077195 |
| 108 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.94117819 |
| 109 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.94117819 |
| 110 | cellular response to interferon-beta (GO:0035458) | 2.93818297 |
| 111 | ribosome assembly (GO:0042255) | 2.91443681 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85136923 |
| 113 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80820515 |
| 114 | negative regulation of viral genome replication (GO:0045071) | 2.80008653 |
| 115 | protein K6-linked ubiquitination (GO:0085020) | 2.77405916 |
| 116 | response to interferon-alpha (GO:0035455) | 2.76765278 |
| 117 | defense response to protozoan (GO:0042832) | 2.76711185 |
| 118 | cellular response to interferon-alpha (GO:0035457) | 2.76512424 |
| 119 | cellular response to type I interferon (GO:0071357) | 2.76492513 |
| 120 | type I interferon signaling pathway (GO:0060337) | 2.76492513 |
| 121 | mitotic metaphase plate congression (GO:0007080) | 2.75896786 |
| 122 | response to interferon-beta (GO:0035456) | 2.72744021 |
| 123 | positive regulation of interferon-beta production (GO:0032728) | 2.72515830 |
| 124 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.70368699 |
| 125 | response to type I interferon (GO:0034340) | 2.69442784 |
| 126 | positive regulation of type 2 immune response (GO:0002830) | 2.67124918 |
| 127 | regulation of activation of Janus kinase activity (GO:0010533) | 2.66352437 |
| 128 | regulation of fever generation (GO:0031620) | 2.66331601 |
| 129 | CENP-A containing nucleosome assembly (GO:0034080) | 2.65700171 |
| 130 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.65591446 |
| 131 | ribosomal large subunit biogenesis (GO:0042273) | 2.64704727 |
| 132 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.64657935 |
| 133 | termination of RNA polymerase III transcription (GO:0006386) | 2.64657935 |
| 134 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64369356 |
| 135 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.62147743 |
| 136 | positive regulation of heat generation (GO:0031652) | 2.60097941 |
| 137 | ribosome biogenesis (GO:0042254) | 2.59435565 |
| 138 | DNA deamination (GO:0045006) | 2.57929330 |
| 139 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.57598491 |
| 140 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.57536609 |
| 141 | chromatin remodeling at centromere (GO:0031055) | 2.56772622 |
| 142 | rRNA modification (GO:0000154) | 2.55920895 |
| 143 | DNA replication checkpoint (GO:0000076) | 2.55558551 |
| 144 | positive regulation of lymphocyte migration (GO:2000403) | 2.54276304 |
| 145 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.54007537 |
| 146 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.53437151 |
| 147 | leukocyte mediated cytotoxicity (GO:0001909) | 2.51986451 |
| 148 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.51648648 |
| 149 | meiotic chromosome segregation (GO:0045132) | 2.51257667 |
| 150 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.50723852 |
| 151 | positive regulation of interleukin-17 production (GO:0032740) | 2.49885069 |
| 152 | regulation of immunoglobulin secretion (GO:0051023) | 2.48542367 |
| 153 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.45335747 |
| 154 | NIK/NF-kappaB signaling (GO:0038061) | 2.45184173 |
| 155 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.44160409 |
| 156 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.42579480 |
| 157 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.42558133 |
| 158 | transcription from RNA polymerase I promoter (GO:0006360) | 2.41532505 |
| 159 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.40872509 |
| 160 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.40146094 |
| 161 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.39538261 |
| 162 | DNA replication initiation (GO:0006270) | 2.39172810 |
| 163 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.38431685 |
| 164 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.38141068 |
| 165 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.36844913 |
| 166 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.36493919 |
| 167 | termination of RNA polymerase I transcription (GO:0006363) | 2.35316606 |
| 168 | cellular response to exogenous dsRNA (GO:0071360) | 2.35241280 |
| 169 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.34840596 |
| 170 | monocyte chemotaxis (GO:0002548) | 2.34453029 |
| 171 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.33920999 |
| 172 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.33920999 |
| 173 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.33920999 |
| 174 | positive regulation of T cell cytokine production (GO:0002726) | 2.33635239 |
| 175 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.33542383 |
| 176 | T-helper 1 type immune response (GO:0042088) | 2.33117378 |
| 177 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.32981884 |
| 178 | rRNA processing (GO:0006364) | 2.32385368 |
| 179 | superoxide metabolic process (GO:0006801) | 2.31917396 |
| 180 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.31696158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.86002946 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.60836137 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.36157441 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.86900817 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.63509625 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.30630210 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.03392591 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.99415704 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.95211077 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76615079 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.74365451 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41256666 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.40870150 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.34476001 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32408403 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28427494 |
| 17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24960590 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.19823778 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16214762 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14721052 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.13973003 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.12401838 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.10048653 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10029481 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.08160805 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05367334 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.03391866 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01026641 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.92207023 |
| 30 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.84779315 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83320763 |
| 32 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74787363 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.71435464 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.71021198 |
| 35 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70929665 |
| 36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.70908646 |
| 37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.66727339 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.66408225 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64357111 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63444536 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.62745477 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61412348 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59634542 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.56472760 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56067749 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.53734600 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53590979 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49968319 |
| 49 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.48512105 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.46057020 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.45087048 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45015033 |
| 53 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.44681631 |
| 54 | EWS_26573619_Chip-Seq_HEK293_Human | 1.44520845 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43151950 |
| 56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.40156027 |
| 57 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37139980 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36613040 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35574663 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34262468 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33903303 |
| 62 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32249052 |
| 63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.32013300 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31975762 |
| 65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.30877403 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29753695 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29121750 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28620041 |
| 69 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27886700 |
| 70 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24693069 |
| 71 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24632104 |
| 72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22873508 |
| 73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22442968 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22374917 |
| 75 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21347162 |
| 76 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.19938225 |
| 77 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19640847 |
| 78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19320886 |
| 79 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.17232644 |
| 80 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.15500997 |
| 81 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.14667263 |
| 82 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12685149 |
| 83 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10594328 |
| 84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10129774 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.08531431 |
| 86 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.08106369 |
| 87 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.08106369 |
| 88 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.08106369 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08065893 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07844143 |
| 91 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07529381 |
| 92 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.06838117 |
| 93 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05950660 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05859099 |
| 95 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05848492 |
| 96 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.03246763 |
| 97 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00981167 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00873675 |
| 99 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.00505708 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95815373 |
| 101 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94198172 |
| 102 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91851628 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91060075 |
| 104 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90634463 |
| 105 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90144387 |
| 106 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88631359 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86979903 |
| 108 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.86500063 |
| 109 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.86486231 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.84999941 |
| 111 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84105289 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.82455960 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81663549 |
| 114 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.81649034 |
| 115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.81619137 |
| 116 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.80871267 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80620676 |
| 118 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80444497 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.80224437 |
| 120 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79992738 |
| 121 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79620415 |
| 122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78861178 |
| 123 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.75690277 |
| 124 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75462179 |
| 125 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.73953509 |
| 126 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.73563237 |
| 127 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.72362261 |
| 128 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.69720779 |
| 129 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.69643082 |
| 130 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.68844428 |
| 131 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.67494818 |
| 132 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.67490692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.70935706 |
| 2 | MP0009785_altered_susceptibility_to | 3.63403948 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.42900167 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.33592042 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.20968571 |
| 6 | MP0008057_abnormal_DNA_replication | 3.07742458 |
| 7 | MP0003724_increased_susceptibility_to | 2.90157785 |
| 8 | MP0003436_decreased_susceptibility_to | 2.71395289 |
| 9 | MP0008058_abnormal_DNA_repair | 2.71059294 |
| 10 | MP0005025_abnormal_response_to | 2.64337030 |
| 11 | MP0006082_CNS_inflammation | 2.63139966 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.60243862 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.59609962 |
| 14 | MP0002419_abnormal_innate_immunity | 2.57742904 |
| 15 | MP0003111_abnormal_nucleus_morphology | 2.52308488 |
| 16 | MP0009697_abnormal_copulation | 2.44482958 |
| 17 | MP0005671_abnormal_response_to | 2.39889307 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.27875631 |
| 19 | MP0003077_abnormal_cell_cycle | 2.23934636 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.19471511 |
| 21 | MP0002723_abnormal_immune_serum | 2.16899898 |
| 22 | MP0008789_abnormal_olfactory_epithelium | 2.07114644 |
| 23 | MP0002938_white_spotting | 2.02766296 |
| 24 | MP0001800_abnormal_humoral_immune | 2.02322258 |
| 25 | MP0003136_yellow_coat_color | 1.99295575 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.97789109 |
| 27 | MP0001790_abnormal_immune_system | 1.91850804 |
| 28 | MP0005387_immune_system_phenotype | 1.91850804 |
| 29 | MP0004957_abnormal_blastocyst_morpholog | 1.89573121 |
| 30 | MP0001819_abnormal_immune_cell | 1.88856415 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.84725277 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.78864608 |
| 33 | MP0003186_abnormal_redox_activity | 1.74353834 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.73837640 |
| 35 | MP0003448_altered_tumor_morphology | 1.73746211 |
| 36 | MP0008007_abnormal_cellular_replicative | 1.73532379 |
| 37 | MP0000685_abnormal_immune_system | 1.72377573 |
| 38 | MP0006035_abnormal_mitochondrial_morpho | 1.66281568 |
| 39 | MP0003718_maternal_effect | 1.61563976 |
| 40 | MP0001529_abnormal_vocalization | 1.60817123 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.60704205 |
| 42 | MP0003303_peritoneal_inflammation | 1.59563373 |
| 43 | MP0010307_abnormal_tumor_latency | 1.59186573 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.58753844 |
| 45 | MP0001853_heart_inflammation | 1.57575880 |
| 46 | MP0008260_abnormal_autophagy | 1.56901867 |
| 47 | MP0002006_tumorigenesis | 1.53800963 |
| 48 | MP0000858_altered_metastatic_potential | 1.51018713 |
| 49 | MP0002160_abnormal_reproductive_system | 1.50479535 |
| 50 | MP0008932_abnormal_embryonic_tissue | 1.47663314 |
| 51 | MP0002405_respiratory_system_inflammati | 1.46931132 |
| 52 | MP0003890_abnormal_embryonic-extraembry | 1.46404162 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.44280337 |
| 54 | MP0000716_abnormal_immune_system | 1.42998329 |
| 55 | MP0009764_decreased_sensitivity_to | 1.42519818 |
| 56 | MP0003567_abnormal_fetal_cardiomyocyte | 1.42368381 |
| 57 | MP0003786_premature_aging | 1.42036041 |
| 58 | MP0002398_abnormal_bone_marrow | 1.41963789 |
| 59 | MP0001845_abnormal_inflammatory_respons | 1.36622367 |
| 60 | MP0002234_abnormal_pharynx_morphology | 1.36065527 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.34000734 |
| 62 | MP0005499_abnormal_olfactory_system | 1.34000734 |
| 63 | MP0008995_early_reproductive_senescence | 1.33335121 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.32547754 |
| 65 | MP0003937_abnormal_limbs/digits/tail_de | 1.31672328 |
| 66 | MP0002396_abnormal_hematopoietic_system | 1.31276233 |
| 67 | MP0003315_abnormal_perineum_morphology | 1.30215574 |
| 68 | MP0001697_abnormal_embryo_size | 1.28718985 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.24350447 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.24350447 |
| 71 | MP0008469_abnormal_protein_level | 1.20812449 |
| 72 | MP0002429_abnormal_blood_cell | 1.20609095 |
| 73 | MP0001286_abnormal_eye_development | 1.20575499 |
| 74 | MP0004947_skin_inflammation | 1.20076339 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.19897512 |
| 76 | MP0000490_abnormal_crypts_of | 1.18712764 |
| 77 | MP0002085_abnormal_embryonic_tissue | 1.18235361 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.17611129 |
| 79 | MP0000049_abnormal_middle_ear | 1.16974876 |
| 80 | MP0001293_anophthalmia | 1.16208965 |
| 81 | MP0002233_abnormal_nose_morphology | 1.15393202 |
| 82 | MP0000689_abnormal_spleen_morphology | 1.13923146 |
| 83 | MP0002722_abnormal_immune_system | 1.13316607 |
| 84 | MP0000383_abnormal_hair_follicle | 1.10357435 |
| 85 | MP0000015_abnormal_ear_pigmentation | 1.10158465 |
| 86 | MP0010155_abnormal_intestine_physiology | 1.09676359 |
| 87 | MP0002084_abnormal_developmental_patter | 1.09281759 |
| 88 | MP0005451_abnormal_body_composition | 1.08842999 |
| 89 | MP0001929_abnormal_gametogenesis | 1.07360430 |
| 90 | MP0001672_abnormal_embryogenesis/_devel | 1.06630890 |
| 91 | MP0005380_embryogenesis_phenotype | 1.06630890 |
| 92 | MP0003828_pulmonary_edema | 1.06470505 |
| 93 | MP0004808_abnormal_hematopoietic_stem | 1.05932791 |
| 94 | MP0002697_abnormal_eye_size | 1.05068568 |
| 95 | MP0005171_absent_coat_pigmentation | 1.05031276 |
| 96 | MP0000350_abnormal_cell_proliferation | 1.04594193 |
| 97 | MP0003941_abnormal_skin_development | 1.04566037 |
| 98 | MP0001145_abnormal_male_reproductive | 1.02911854 |
| 99 | MP0001485_abnormal_pinna_reflex | 1.02746489 |
| 100 | MP0002163_abnormal_gland_morphology | 1.02603612 |
| 101 | MP0004510_myositis | 1.02029636 |
| 102 | MP0005389_reproductive_system_phenotype | 1.01638281 |
| 103 | MP0000313_abnormal_cell_death | 1.01620780 |
| 104 | MP0001764_abnormal_homeostasis | 1.01315702 |
| 105 | MP0002837_dystrophic_cardiac_calcinosis | 0.99167669 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.99056166 |
| 107 | MP0000653_abnormal_sex_gland | 0.98660188 |
| 108 | MP0005174_abnormal_tail_pigmentation | 0.97470373 |
| 109 | MP0008877_abnormal_DNA_methylation | 0.95530606 |
| 110 | MP0000358_abnormal_cell_content/ | 0.94261212 |
| 111 | MP0002080_prenatal_lethality | 0.93849239 |
| 112 | MP0009278_abnormal_bone_marrow | 0.93181053 |
| 113 | MP0003119_abnormal_digestive_system | 0.92888569 |
| 114 | MP0010352_gastrointestinal_tract_polyps | 0.91655432 |
| 115 | MP0003011_delayed_dark_adaptation | 0.91222282 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.90143616 |
| 117 | MP0002111_abnormal_tail_morphology | 0.89073427 |
| 118 | MP0001188_hyperpigmentation | 0.88528438 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.87502467 |
| 120 | MP0002095_abnormal_skin_pigmentation | 0.87169892 |
| 121 | MP0003763_abnormal_thymus_physiology | 0.85461917 |
| 122 | MP0002132_abnormal_respiratory_system | 0.84809455 |
| 123 | MP0003121_genomic_imprinting | 0.84137743 |
| 124 | MP0003984_embryonic_growth_retardation | 0.83675079 |
| 125 | MP0001881_abnormal_mammary_gland | 0.82809279 |
| 126 | MP0002088_abnormal_embryonic_growth/wei | 0.82753197 |
| 127 | MP0004147_increased_porphyrin_level | 0.82752112 |
| 128 | MP0000647_abnormal_sebaceous_gland | 0.81335937 |
| 129 | MP0002751_abnormal_autonomic_nervous | 0.79987982 |
| 130 | MP0004381_abnormal_hair_follicle | 0.79544905 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.77649085 |
| 132 | MP0002210_abnormal_sex_determination | 0.77452563 |
| 133 | MP0005391_vision/eye_phenotype | 0.77063625 |
| 134 | MP0005253_abnormal_eye_physiology | 0.75194991 |
| 135 | MP0003938_abnormal_ear_development | 0.74556379 |
| 136 | MP0002998_abnormal_bone_remodeling | 0.74438791 |
| 137 | MP0001346_abnormal_lacrimal_gland | 0.74062469 |
| 138 | MP0000343_altered_response_to | 0.74061594 |
| 139 | MP0000703_abnormal_thymus_morphology | 0.74010568 |
| 140 | MP0002102_abnormal_ear_morphology | 0.73937134 |
| 141 | MP0008004_abnormal_stomach_pH | 0.73748338 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.73206947 |
| 143 | MP0005390_skeleton_phenotype | 0.72862965 |
| 144 | MP0000627_abnormal_mammary_gland | 0.72854652 |
| 145 | MP0005310_abnormal_salivary_gland | 0.72414734 |
| 146 | MP0009672_abnormal_birth_weight | 0.72157096 |
| 147 | MP0003123_paternal_imprinting | 0.71791683 |
| 148 | MP0004197_abnormal_fetal_growth/weight/ | 0.71100827 |
| 149 | MP0001119_abnormal_female_reproductive | 0.70233489 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.70173536 |
| 151 | MP0001730_embryonic_growth_arrest | 0.70018430 |
| 152 | MP0003755_abnormal_palate_morphology | 0.66923329 |
| 153 | MP0003698_abnormal_male_reproductive | 0.65940750 |
| 154 | MP0002638_abnormal_pupillary_reflex | 0.64205641 |
| 155 | MP0001986_abnormal_taste_sensitivity | 0.63341217 |
| 156 | MP0005408_hypopigmentation | 0.63281439 |
| 157 | MP0003950_abnormal_plasma_membrane | 0.63079748 |
| 158 | MP0004782_abnormal_surfactant_physiolog | 0.62950613 |
| 159 | MP0001919_abnormal_reproductive_system | 0.62931410 |
| 160 | MP0000579_abnormal_nail_morphology | 0.62503908 |
| 161 | MP0002736_abnormal_nociception_after | 0.62357922 |
| 162 | MP0008872_abnormal_physiological_respon | 0.61846500 |
| 163 | MP0009763_increased_sensitivity_to | 0.61181414 |
| 164 | MP0004215_abnormal_myocardial_fiber | 0.60929285 |
| 165 | MP0000371_diluted_coat_color | 0.60033252 |
| 166 | MP0003646_muscle_fatigue | 0.57047908 |
| 167 | MP0005395_other_phenotype | 0.55662413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.70515401 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.10364742 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.05118980 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.97511863 |
| 5 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.58140126 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.56503966 |
| 7 | Acute encephalopathy (HP:0006846) | 4.44144474 |
| 8 | Mitochondrial inheritance (HP:0001427) | 4.37373130 |
| 9 | Increased hepatocellular lipid droplets (HP:0006565) | 4.34499289 |
| 10 | Chromsome breakage (HP:0040012) | 4.30924962 |
| 11 | Progressive macrocephaly (HP:0004481) | 4.20449450 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 4.14934404 |
| 13 | Increased CSF lactate (HP:0002490) | 4.10230958 |
| 14 | Lipid accumulation in hepatocytes (HP:0006561) | 3.93171648 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.89907900 |
| 16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.82074541 |
| 17 | Macrocytic anemia (HP:0001972) | 3.81151552 |
| 18 | Prostate neoplasm (HP:0100787) | 3.79593173 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 3.76557700 |
| 20 | Hepatocellular necrosis (HP:0001404) | 3.66849012 |
| 21 | Stomatitis (HP:0010280) | 3.64996309 |
| 22 | Abnormality of macrophages (HP:0004311) | 3.64137384 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.59094203 |
| 24 | Obstructive lung disease (HP:0006536) | 3.59094203 |
| 25 | Birth length less than 3rd percentile (HP:0003561) | 3.45173686 |
| 26 | Cerebral edema (HP:0002181) | 3.39402176 |
| 27 | Hepatic necrosis (HP:0002605) | 3.36627378 |
| 28 | Colon cancer (HP:0003003) | 3.35415302 |
| 29 | Parakeratosis (HP:0001036) | 3.21607025 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 3.10260039 |
| 31 | Duplicated collecting system (HP:0000081) | 3.10175817 |
| 32 | Recurrent skin infections (HP:0001581) | 3.05653925 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.04684061 |
| 34 | Increased IgM level (HP:0003496) | 3.01036896 |
| 35 | Aplastic anemia (HP:0001915) | 2.98818738 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.96065688 |
| 37 | Cleft eyelid (HP:0000625) | 2.95093886 |
| 38 | Increased serum lactate (HP:0002151) | 2.94023853 |
| 39 | Gingivitis (HP:0000230) | 2.89615988 |
| 40 | Methylmalonic acidemia (HP:0002912) | 2.81679964 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79698160 |
| 42 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79698160 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.76805589 |
| 44 | Reticulocytopenia (HP:0001896) | 2.69111396 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.68014958 |
| 46 | Recurrent fungal infections (HP:0002841) | 2.66801068 |
| 47 | Basal ganglia calcification (HP:0002135) | 2.65371138 |
| 48 | Leukodystrophy (HP:0002415) | 2.63386237 |
| 49 | Meckel diverticulum (HP:0002245) | 2.62648487 |
| 50 | Poor head control (HP:0002421) | 2.62262288 |
| 51 | Breast hypoplasia (HP:0003187) | 2.62183259 |
| 52 | Agnosia (HP:0010524) | 2.61106441 |
| 53 | Abnormality of the preputium (HP:0100587) | 2.60317449 |
| 54 | Lactic acidosis (HP:0003128) | 2.60073435 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.57559760 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.57301882 |
| 57 | Abnormality of chromosome stability (HP:0003220) | 2.56993613 |
| 58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.56886173 |
| 59 | Abnormality of the renal collecting system (HP:0004742) | 2.56004483 |
| 60 | Abnormality of the ileum (HP:0001549) | 2.52866287 |
| 61 | Congenital, generalized hypertrichosis (HP:0004540) | 2.50386122 |
| 62 | Respiratory failure (HP:0002878) | 2.49425829 |
| 63 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.49078300 |
| 64 | Oral leukoplakia (HP:0002745) | 2.49043869 |
| 65 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.47426017 |
| 66 | Type I transferrin isoform profile (HP:0003642) | 2.47191656 |
| 67 | Rough bone trabeculation (HP:0100670) | 2.46772036 |
| 68 | Optic neuritis (HP:0100653) | 2.46006951 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.46006951 |
| 70 | Bone marrow hypocellularity (HP:0005528) | 2.45387514 |
| 71 | Ectopic kidney (HP:0000086) | 2.42796159 |
| 72 | Abnormality of alanine metabolism (HP:0010916) | 2.42340172 |
| 73 | Hyperalaninemia (HP:0003348) | 2.42340172 |
| 74 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42340172 |
| 75 | Exercise intolerance (HP:0003546) | 2.41961778 |
| 76 | Vasculitis (HP:0002633) | 2.35916081 |
| 77 | Respiratory difficulties (HP:0002880) | 2.34904820 |
| 78 | Microvesicular hepatic steatosis (HP:0001414) | 2.33317055 |
| 79 | Increased serum pyruvate (HP:0003542) | 2.32875534 |
| 80 | Abnormality of the labia minora (HP:0012880) | 2.32435990 |
| 81 | Absent radius (HP:0003974) | 2.32087806 |
| 82 | Pustule (HP:0200039) | 2.31965330 |
| 83 | Clubbing of toes (HP:0100760) | 2.31672282 |
| 84 | Prolonged neonatal jaundice (HP:0006579) | 2.29110955 |
| 85 | Recurrent lower respiratory tract infections (HP:0002783) | 2.28554651 |
| 86 | Recurrent viral infections (HP:0004429) | 2.25523394 |
| 87 | Abnormal trabecular bone morphology (HP:0100671) | 2.23810291 |
| 88 | Methylmalonic aciduria (HP:0012120) | 2.22584861 |
| 89 | Carpal bone hypoplasia (HP:0001498) | 2.20558101 |
| 90 | Premature graying of hair (HP:0002216) | 2.20450589 |
| 91 | Optic disc pallor (HP:0000543) | 2.18641499 |
| 92 | Megaloblastic anemia (HP:0001889) | 2.18413270 |
| 93 | Abnormality of serum amino acid levels (HP:0003112) | 2.18365602 |
| 94 | Abnormal lung lobation (HP:0002101) | 2.17770364 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.14854417 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.14854417 |
| 97 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.14077150 |
| 98 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.14077150 |
| 99 | Abnormal protein glycosylation (HP:0012346) | 2.14077150 |
| 100 | Abnormal glycosylation (HP:0012345) | 2.14077150 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.10830289 |
| 102 | Absent forearm bone (HP:0003953) | 2.10513712 |
| 103 | Aplasia involving forearm bones (HP:0009822) | 2.10513712 |
| 104 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.09232940 |
| 105 | Tracheoesophageal fistula (HP:0002575) | 2.08887489 |
| 106 | Hepatosplenomegaly (HP:0001433) | 2.07263309 |
| 107 | Lethargy (HP:0001254) | 2.07236937 |
| 108 | Leukopenia (HP:0001882) | 2.07112342 |
| 109 | Pancytopenia (HP:0001876) | 2.05789860 |
| 110 | Hyperglycinemia (HP:0002154) | 2.05418817 |
| 111 | Thick nail (HP:0001805) | 2.05008174 |
| 112 | Myelodysplasia (HP:0002863) | 2.04048607 |
| 113 | Orchitis (HP:0100796) | 2.03904502 |
| 114 | Leukocytosis (HP:0001974) | 2.03650249 |
| 115 | Increased muscle lipid content (HP:0009058) | 2.01241328 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 2.00904299 |
| 117 | Abnormality of homocysteine metabolism (HP:0010919) | 2.00371441 |
| 118 | Homocystinuria (HP:0002156) | 2.00371441 |
| 119 | Stenosis of the external auditory canal (HP:0000402) | 1.99720473 |
| 120 | Lymphoma (HP:0002665) | 1.99171935 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.98856482 |
| 122 | Multiple enchondromatosis (HP:0005701) | 1.98666278 |
| 123 | Fused cervical vertebrae (HP:0002949) | 1.97320477 |
| 124 | Petechiae (HP:0000967) | 1.97067687 |
| 125 | Abnormality of the anterior horn cell (HP:0006802) | 1.96843191 |
| 126 | Degeneration of anterior horn cells (HP:0002398) | 1.96843191 |
| 127 | Pallor (HP:0000980) | 1.96838259 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.96409861 |
| 129 | Pancreatic cysts (HP:0001737) | 1.96272682 |
| 130 | Myositis (HP:0100614) | 1.96124975 |
| 131 | Abnormality of the duodenum (HP:0002246) | 1.95838848 |
| 132 | Absent septum pellucidum (HP:0001331) | 1.95826823 |
| 133 | Cellulitis (HP:0100658) | 1.94412730 |
| 134 | Abnormality of renal resorption (HP:0011038) | 1.94375099 |
| 135 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.94074630 |
| 136 | Triphalangeal thumb (HP:0001199) | 1.91490528 |
| 137 | Pancreatic fibrosis (HP:0100732) | 1.91146163 |
| 138 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90603645 |
| 139 | Absent thumb (HP:0009777) | 1.89607034 |
| 140 | Patellar aplasia (HP:0006443) | 1.88366438 |
| 141 | Sparse eyelashes (HP:0000653) | 1.87907700 |
| 142 | IgG deficiency (HP:0004315) | 1.86217055 |
| 143 | Porencephaly (HP:0002132) | 1.85931008 |
| 144 | Septo-optic dysplasia (HP:0100842) | 1.85299936 |
| 145 | Hypoplasia of the pons (HP:0012110) | 1.83602421 |
| 146 | Amniotic constriction ring (HP:0009775) | 1.83494516 |
| 147 | Abnormality of placental membranes (HP:0011409) | 1.83494516 |
| 148 | Abnormality of the septum pellucidum (HP:0007375) | 1.83438253 |
| 149 | Nausea (HP:0002018) | 1.82307986 |
| 150 | Meningitis (HP:0001287) | 1.81715526 |
| 151 | Horseshoe kidney (HP:0000085) | 1.79982716 |
| 152 | Vacuolated lymphocytes (HP:0001922) | 1.79626626 |
| 153 | Pendular nystagmus (HP:0012043) | 1.79462475 |
| 154 | Small intestinal stenosis (HP:0012848) | 1.78777193 |
| 155 | Duodenal stenosis (HP:0100867) | 1.78777193 |
| 156 | Eosinophilia (HP:0001880) | 1.77676690 |
| 157 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.77567811 |
| 158 | Abnormal number of incisors (HP:0011064) | 1.77460542 |
| 159 | Abnormality of the pons (HP:0007361) | 1.77105789 |
| 160 | Impulsivity (HP:0100710) | 1.76110604 |
| 161 | Exertional dyspnea (HP:0002875) | 1.75859438 |
| 162 | Periodontitis (HP:0000704) | 1.74644847 |
| 163 | Molar tooth sign on MRI (HP:0002419) | 1.74373294 |
| 164 | Abnormality of midbrain morphology (HP:0002418) | 1.74373294 |
| 165 | Urticaria (HP:0001025) | 1.73830022 |
| 166 | Sloping forehead (HP:0000340) | 1.73356355 |
| 167 | CNS demyelination (HP:0007305) | 1.72811892 |
| 168 | Cerebral hypomyelination (HP:0006808) | 1.72356067 |
| 169 | Rectal fistula (HP:0100590) | 1.72134418 |
| 170 | Rectovaginal fistula (HP:0000143) | 1.72134418 |
| 171 | Abnormality of eosinophils (HP:0001879) | 1.72030358 |
| 172 | Abnormality of the carotid arteries (HP:0005344) | 1.71825857 |
| 173 | Conical tooth (HP:0000698) | 1.71766521 |
| 174 | Cellular immunodeficiency (HP:0005374) | 1.71569085 |
| 175 | Abnormality of T cell number (HP:0011839) | 1.70745123 |
| 176 | Amaurosis fugax (HP:0100576) | 1.69579655 |
| 177 | Abnormality of DNA repair (HP:0003254) | 1.68794722 |
| 178 | Granulocytopenia (HP:0001913) | 1.67894497 |
| 179 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.67196494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 5.17045130 |
| 2 | VRK2 | 4.64585643 |
| 3 | IRAK3 | 3.21326579 |
| 4 | IRAK4 | 3.05664050 |
| 5 | MAP3K14 | 2.98654522 |
| 6 | EIF2AK1 | 2.92875777 |
| 7 | BLK | 2.62871489 |
| 8 | TAF1 | 2.58919432 |
| 9 | BUB1 | 2.57263310 |
| 10 | NUAK1 | 2.53915990 |
| 11 | RIPK4 | 2.48095059 |
| 12 | NEK1 | 2.37622903 |
| 13 | STK16 | 2.25959742 |
| 14 | WEE1 | 2.23588988 |
| 15 | PLK4 | 2.19551870 |
| 16 | NME2 | 2.18851167 |
| 17 | EIF2AK2 | 2.08571019 |
| 18 | IKBKB | 2.01607554 |
| 19 | PIM2 | 1.95473598 |
| 20 | SRPK1 | 1.95289626 |
| 21 | TXK | 1.92302644 |
| 22 | NME1 | 1.87790901 |
| 23 | EIF2AK3 | 1.74394500 |
| 24 | ZAK | 1.68183198 |
| 25 | TBK1 | 1.61489318 |
| 26 | MKNK1 | 1.59379320 |
| 27 | IKBKE | 1.56606629 |
| 28 | STK4 | 1.52987252 |
| 29 | TLK1 | 1.48888482 |
| 30 | YES1 | 1.48731224 |
| 31 | VRK1 | 1.47291012 |
| 32 | MKNK2 | 1.46521523 |
| 33 | TYK2 | 1.46084629 |
| 34 | MST4 | 1.44080873 |
| 35 | JAK3 | 1.39564987 |
| 36 | CDK19 | 1.35540610 |
| 37 | RPS6KA4 | 1.27688606 |
| 38 | TNIK | 1.23586020 |
| 39 | PIM1 | 1.21799494 |
| 40 | BRSK2 | 1.21080991 |
| 41 | WNK3 | 1.19639814 |
| 42 | CDC7 | 1.17455582 |
| 43 | PLK1 | 1.11771474 |
| 44 | PASK | 1.11377359 |
| 45 | BMPR2 | 1.09760686 |
| 46 | CCNB1 | 1.09446335 |
| 47 | NEK6 | 1.07848982 |
| 48 | TTK | 1.07405397 |
| 49 | ATR | 1.06376217 |
| 50 | MAPKAPK5 | 1.04804964 |
| 51 | CDK8 | 1.03173419 |
| 52 | TRIM28 | 1.01276116 |
| 53 | MARK3 | 0.98664354 |
| 54 | ABL2 | 0.98322046 |
| 55 | PLK3 | 0.98150267 |
| 56 | ACVR1B | 0.98143244 |
| 57 | CHUK | 0.96274500 |
| 58 | MAP4K1 | 0.95608466 |
| 59 | BRD4 | 0.94322284 |
| 60 | NEK2 | 0.93622161 |
| 61 | TSSK6 | 0.93523888 |
| 62 | CLK1 | 0.93499647 |
| 63 | MAP3K13 | 0.93245428 |
| 64 | CDK7 | 0.92751429 |
| 65 | BCR | 0.88437630 |
| 66 | BCKDK | 0.85254889 |
| 67 | LYN | 0.85113427 |
| 68 | NEK9 | 0.84150143 |
| 69 | PDK2 | 0.84072289 |
| 70 | EPHA2 | 0.83729540 |
| 71 | MAP4K2 | 0.81010043 |
| 72 | ERBB4 | 0.79932528 |
| 73 | PNCK | 0.79402397 |
| 74 | RPS6KB2 | 0.75047930 |
| 75 | KIT | 0.74240026 |
| 76 | AURKB | 0.73821647 |
| 77 | DYRK3 | 0.72248763 |
| 78 | AKT3 | 0.71919994 |
| 79 | PLK2 | 0.70820558 |
| 80 | STK38L | 0.70238026 |
| 81 | BRSK1 | 0.70154392 |
| 82 | CDK12 | 0.69508932 |
| 83 | IRAK1 | 0.68023143 |
| 84 | CHEK2 | 0.67115154 |
| 85 | ALK | 0.66857955 |
| 86 | MUSK | 0.66621080 |
| 87 | TESK2 | 0.65803901 |
| 88 | LCK | 0.65026486 |
| 89 | STK3 | 0.64739686 |
| 90 | TGFBR1 | 0.64346175 |
| 91 | RPS6KA5 | 0.63606979 |
| 92 | BMPR1B | 0.63435541 |
| 93 | OXSR1 | 0.60557671 |
| 94 | TEC | 0.60256487 |
| 95 | JAK1 | 0.60128604 |
| 96 | IRAK2 | 0.58144765 |
| 97 | CSNK1G1 | 0.56157140 |
| 98 | SYK | 0.55852961 |
| 99 | CSK | 0.55768610 |
| 100 | CSNK2A1 | 0.54347363 |
| 101 | CHEK1 | 0.54332939 |
| 102 | FGR | 0.54142747 |
| 103 | CDK4 | 0.53818690 |
| 104 | MELK | 0.53344764 |
| 105 | ARAF | 0.52072202 |
| 106 | CSNK1E | 0.52059386 |
| 107 | ADRBK2 | 0.50931426 |
| 108 | BTK | 0.50811852 |
| 109 | GRK1 | 0.50761019 |
| 110 | FGFR1 | 0.48042870 |
| 111 | DYRK2 | 0.47608922 |
| 112 | STK24 | 0.47337950 |
| 113 | DMPK | 0.47236975 |
| 114 | BRAF | 0.47162288 |
| 115 | ATM | 0.46656325 |
| 116 | MAP3K8 | 0.46414703 |
| 117 | CSNK1G3 | 0.45693214 |
| 118 | STK10 | 0.45453186 |
| 119 | PRKCD | 0.45408333 |
| 120 | HCK | 0.45250308 |
| 121 | BMX | 0.44309364 |
| 122 | MAP3K5 | 0.43496895 |
| 123 | ABL1 | 0.42418532 |
| 124 | CDK3 | 0.41368616 |
| 125 | CSNK2A2 | 0.40924855 |
| 126 | CSNK1G2 | 0.40256070 |
| 127 | MET | 0.39907962 |
| 128 | CDK2 | 0.39655253 |
| 129 | CDK1 | 0.39216062 |
| 130 | WNK4 | 0.37661447 |
| 131 | ZAP70 | 0.37525319 |
| 132 | DAPK1 | 0.37359531 |
| 133 | ERBB3 | 0.36007731 |
| 134 | AURKA | 0.35629740 |
| 135 | TRPM7 | 0.35580359 |
| 136 | SIK3 | 0.35473846 |
| 137 | CDK9 | 0.35098584 |
| 138 | SCYL2 | 0.33763152 |
| 139 | PRKDC | 0.33745708 |
| 140 | INSRR | 0.33403346 |
| 141 | STK39 | 0.32761097 |
| 142 | MAP3K10 | 0.32745368 |
| 143 | ILK | 0.29524034 |
| 144 | NLK | 0.29505223 |
| 145 | PRKCG | 0.27661393 |
| 146 | CSNK1A1L | 0.27334657 |
| 147 | KDR | 0.25960210 |
| 148 | FRK | 0.25284346 |
| 149 | PAK4 | 0.23868355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.46724332 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.15843594 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.11671279 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.94009923 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.72524490 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.66088256 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.35043488 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.33840281 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19789192 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15767610 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.15301068 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.13941180 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.04963397 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 2.01783492 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.99030848 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.95989102 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.86438310 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.83776521 |
| 19 | Spliceosome_Homo sapiens_hsa03040 | 1.83330531 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81849604 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.81247189 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.80109925 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77893381 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.76832387 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76197935 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.71381571 |
| 27 | RNA transport_Homo sapiens_hsa03013 | 1.67827100 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66189018 |
| 29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.63240566 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.61570451 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.59966556 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.49773550 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.48068766 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47736572 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.45938036 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.39370347 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.35198324 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33607012 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31280526 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.30053945 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27811381 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27357106 |
| 43 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27176531 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26688588 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26215369 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25291309 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22703653 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22624433 |
| 49 | Tuberculosis_Homo sapiens_hsa05152 | 1.22485040 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19019123 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17887601 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.17429255 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.16650554 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 1.11004835 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08876516 |
| 56 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05907139 |
| 57 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04296872 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97314092 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96662081 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94748876 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.94669837 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.89728409 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.89154463 |
| 64 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88194134 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85523678 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85482237 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82724344 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81494300 |
| 69 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81410584 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81231420 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.77732551 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.76791237 |
| 73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74558362 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.71402029 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69941669 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68981371 |
| 77 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67875298 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67610135 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.66370382 |
| 80 | Hepatitis B_Homo sapiens_hsa05161 | 0.65634662 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64312743 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63936050 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63084507 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62062615 |
| 85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61680240 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60030070 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59501651 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59349037 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.58322741 |
| 90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58214545 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56172954 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55167145 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53018203 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53010469 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52970252 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52771865 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52603927 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52299312 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51124980 |
| 100 | Peroxisome_Homo sapiens_hsa04146 | 0.50002655 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49285296 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48702439 |
| 103 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48268648 |
| 104 | Lysosome_Homo sapiens_hsa04142 | 0.48038687 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47060086 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46781481 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46255757 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45910053 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44983019 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44871656 |
| 111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44284761 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43324908 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42645988 |
| 114 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39404341 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37969550 |
| 116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36873178 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36716956 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36600087 |
| 119 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36452577 |
| 120 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36130133 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36057046 |
| 122 | Phototransduction_Homo sapiens_hsa04744 | 0.35347024 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33647461 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33233223 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32963344 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32705664 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.31048918 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30994460 |
| 129 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30494538 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29305072 |
| 131 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28161172 |
| 132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27675803 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27649491 |
| 134 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26844999 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.26759345 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.25615689 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25473679 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24867858 |
| 139 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24468563 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.22689462 |
| 141 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.21617618 |
| 142 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20707683 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20263206 |
| 144 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20247076 |
| 145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.19668090 |
| 146 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.17528798 |
| 147 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.16681313 |
| 148 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16385241 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.14676845 |
| 150 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14534189 |
| 151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.13226892 |
| 152 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.12879705 |
| 153 | Alcoholism_Homo sapiens_hsa05034 | 0.12583284 |
| 154 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.12575192 |
| 155 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.11935907 |
| 156 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.11759782 |
| 157 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.11012520 |
| 158 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07659053 |
| 159 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.05977208 |
| 160 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.05801175 |
| 161 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02923199 |

